The US FDA’s proposal to consider the reclassification of electroconvulsive therapy (ECT) devices from class III to class II has prompted a flood of comments from people fiercely for, and strongly against, a change. One organisation said Monday that reclassification would be an infringement ...
Please Login to read the full article.
